When was Headlands Research founded?

Headlands Research was founded in 2018.

Where is Headlands Research located?

Headlands Research is headquartered in San Francisco, United States.

Who is the current CEO of Headlands Research?

Mark Blumling of Headlands Research.

How many employees does Headlands Research have?

As of Jul 01, 2024, the latest employee count at Headlands Research is 64.

Is Headlands Research a funded company?

Headlands Research is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Headlands Research rank among its competitors?

Headlands Research ranks 14th amongst 218 active competitors, of which 13 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Geneva, which secured $187K in May, 2025.

Who are the top competitors of Headlands Research?

Headlands Research's top competitors include Biocytogen, Takeda and RxCelerate. Among them, Geneva secured the most recent funding round in May, 2025.

Headlands Research - 2026 Company Profile, Team, Funding & Competitors

Headlands Research is an acquired company based in San Francisco (United States), founded in 2018 by Mark Blumling. It operates as a Provider of clinical research services. The company has 218 active competitors, including 13 funded and 46 that have exited. Its top competitors include companies like Biocytogen, Takeda and RxCelerate.

Company Details

Website: headlandsresearch.com
Social

Key Metrics

Founded Year

2018

Location

San Francisco, United States

Stage

Acquired

Investors

KKR

Ranked

14^th among 218 active competitors

Employee Count

64 as on Jul 01, 2024

Investment & Acquisitions

Trial Management Associates & 5 more

Similar Companies

Biocytogen & 266 more

Exit Details

Acquired by Thomas H Lee Partners (Aug 18, 2025)

View Headlands Research's full profile

Headlands Research got acquired by Thomas H Lee Partners on Aug 18, 2025 at an acquisition amount of $600M. It was facilitated by Paul, Weiss, Rifkind, Wharton & Garrison, McDermott Will & Emery, Jefferies and 3 more.

Click here to take a look at Headlands Research's acquisition in detail

Headlands Research is a funded company. Headlands Research has 1 institutional investor.

View details of Headlands Research's funding rounds and investors

The founders of Headlands Research is Mark Blumling.

Here are the details of Headlands Research's key team members:

Mark Blumling: CEO, President, Founder and Board Member at Headlands Research of Headlands Research and founder of 1 other company.

View details of Headlands Research's Founder profiles and Board Members

Headlands Research's employee count trend

Headlands Research has 64 employees as of Jul 24. Here is Headlands Research's employee count trend over the years:

Employee count trend for Headlands Research

Uncover Headlands Research's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Headlands Research include Biocytogen, Takeda and RxCelerate. Here is the list of Top 10 competitors of Headlands Research, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Biocytogen 2008, Wakefield (United States), Public	Provider of integrated solutions for next-generation antibody drug development	$301M	CMB International Capital, SDIC & 11 others	67/100
2nd	Takeda 1781, Tokyo (Japan), Public	Large diversified pharma company	-	Digital Pharma Lab, Kleiner Perkins & 7 others	64/100
3rd	RxCelerate 2012, Babraham (United Kingdom), Seed	Provider of pre-clinical contract research services	-	Total Medical Ventures	56/100
4th	BioQual 1981, Rockville (United States), Public	Integrated CRO focused on infectious diseases	-	-	53/100
5th	Likarda 2012, Kansas City (United States), Series A	Developer of 3D cell cultures for regenerative medicine	$4M	Werth Ventures, HHS	53/100
6th	Geneva 1993, United States, Funding Raised	Provider of clinical research services	-	Maryland Stem Cell Research Fund, Europa & 2 others	52/100
7th	Gubra 2008, Horsholm (Denmark), Public	Preclinical CRO focussed on developing treatments for NAFLD/NASH, diabetes, and obesity	-	-	49/100
8th	Yashraj Biotechnology 1999, Mumbai (India), Early Stage	Provider of recombinant antigens and antibodies for diagnostic and research	$492K	Supreme Industries, Chartered Finance Management ... & 3 others	47/100
9th	Tigermed 2004, Hangzhou (China), Public	Provider of drug development and pre clinical services	-	CDG Capital, Qiming Venture Partners	45/100
10th	Javelin Biotech 2019, Woburn (United States), Funding Raised	CRO focused on providing drug discovery and preclinical study services	-	Shah Capital Partners, Social Starts & 2 others	45/100
14th	Headlands Research 2018, San Francisco (United States), Acquired	Provider of clinical research services	-	KKR	41/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Headlands Research's competitors? Click here to see the top ones

Headlands Research has not made any investments yet. Headlands Research has made 6 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Nov 04, 2024	Acquisition	Trial Management Associates	2009	Wilmington (United States)
Feb 29, 2024	Acquisition	Pharmasite Research	1999	Baltimore (United States)
Jul 27, 2023	Acquisition	AMCR Institute	2007	Escondido (United States)